1
|
Ricke IJ, Spaulding AB, Rajtar NN, Benton EM, Anderson IG, Lundberg L, Mussiel A, Nguyen RHN. Predictors of willingness to receive updated 2023-2024 COVID-19 booster vaccines among a convenience sample in Minnesota. Vaccine 2024:S0264-410X(24)00480-8. [PMID: 38641495 DOI: 10.1016/j.vaccine.2024.04.053] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/16/2024] [Revised: 04/15/2024] [Accepted: 04/16/2024] [Indexed: 04/21/2024]
Abstract
OBJECTIVES To determine factors associated with intention to receive recommended COVID-19 booster vaccines in 2023-2024. METHODS A cross-sectional study of 1,256 individuals at Minnesota State and County fairs was conducted to assess their intention to receive a COVID-19 booster vaccine in the coming year if recommended. The association between booster intention and multiple factors believed to influence willingness to receive the vaccine, including perceived vaccine safety, perceived risk of COVID-19, public health knowledge, fear of future pandemics, and political affiliation, were analyzed using ordinal logistic regression and adjusted odds ratios (aOR). RESULTS Intention to receive a COVID-19 booster vaccine was high among our participants with 56% reporting they were extremely likely to receive the vaccine this year and another 15% reporting that they were likely to do the same. A strong association with getting a booster vaccine was found between perceived vaccine safety (aOR: 15.3, 95% CI: 10.6-22.2), perceived COVID-19 risk (aOR: 3.5, 95% CI: 2.4-5.1), pandemic fear (aOR: 3.4, 95% CI: 2.4-4.8), public health knowledge (aOR: 1.3, 95% CI: 0.9-1.8), and democrat political affiliation (aOR: 2.8, 95%CI: 1.8-4.4). CONCLUSIONS Our study emphasizes the importance of perceived vaccine safety as a predictor of intention to accept COVID-19 vaccines and highlights the continued need to effectively communicate with the public about the safety of vaccines.
Collapse
Affiliation(s)
- I J Ricke
- Division of Epidemiology & Community Health, School of Public Health, University of Minnesota, Minneapolis, MN 55454, USA.
| | - A B Spaulding
- Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA
| | - N N Rajtar
- Department of Plant Pathology, University of Minnesota, St. Paul, MN 55108, USA
| | - E M Benton
- Division of Epidemiology & Community Health, School of Public Health, University of Minnesota, Minneapolis, MN 55454, USA
| | - I G Anderson
- Division of Epidemiology & Community Health, School of Public Health, University of Minnesota, Minneapolis, MN 55454, USA
| | - L Lundberg
- Division of Epidemiology & Community Health, School of Public Health, University of Minnesota, Minneapolis, MN 55454, USA
| | - A Mussiel
- Division of Epidemiology & Community Health, School of Public Health, University of Minnesota, Minneapolis, MN 55454, USA
| | - R H N Nguyen
- Division of Epidemiology & Community Health, School of Public Health, University of Minnesota, Minneapolis, MN 55454, USA
| |
Collapse
|
2
|
Bygdell M, Leach S, Lundberg L, Gyll D, Martikainen J, Santosa A, Li H, Gisslén M, Nyberg F. A comprehensive characterization of patients diagnosed with post-COVID-19 condition in Sweden 16 months after the introduction of the International Classification of Diseases Tenth Revision diagnosis code (U09.9): a population-based cohort study. Int J Infect Dis 2023; 126:104-113. [PMID: 36410693 PMCID: PMC9678230 DOI: 10.1016/j.ijid.2022.11.021] [Citation(s) in RCA: 10] [Impact Index Per Article: 10.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/11/2022] [Revised: 10/26/2022] [Accepted: 11/14/2022] [Indexed: 11/22/2022] Open
Abstract
OBJECTIVES The objective of this study was to provide a comprehensive characterization of patients diagnosed with post-COVID-19 condition (PCC) during the first 16 months of use of the International Classification of Diseases revision 10 (ICD-10) diagnosis code U09.9 in Sweden. METHODS We used data from national registers and primary health care databases for all adult inhabitants of the two largest regions in Sweden, comprising 4.1 million inhabitants (approximately 40% of the Swedish population). We present the cumulative incidence and incidence rate of PCC overall and among subgroups and describe patients with COVID-19 with or without PCC regarding sociodemographic characteristics, comorbidities, subsequent diseases, COVID-19 severity, and virus variants. RESULTS Of all registered COVID-19 cases available for PCC diagnosis (n = 506,107), 2.0% (n = 10,196) had been diagnosed with PCC using ICD-10 code U09.9 as of February 15, 2022 in the two largest regions in Sweden. The cumulative incidence was higher among women than men (2.3% vs 1.6%, P <0.001). The majority of PCC cases (n = 7162, 70.2%) had not been hospitalized for COVID-19. This group was more commonly female (69.9% vs 52.9%, P <0.001), had a tertiary education (51.0% vs 44.1%, P <0.001), and was older (median age difference 5.7 years, P <0.001) than non-hospitalized patients with COVID-19 without PCC. CONCLUSION This characterization furthers the understanding of patients diagnosed with PCC and could support policy makers with appropriate societal and health care resource allocation.
Collapse
Affiliation(s)
- Maria Bygdell
- Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; School of Public Health and Community Medicine, Institute of Medicine, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
| | - Susannah Leach
- Department of Microbiology and Immunology, Institute of Biomedicine, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Region Västra Götaland, Department of Clinical Pharmacology, Sahlgrenska University Hospital, Gothenburg, Sweden
| | - Lisa Lundberg
- Department of Microbiology and Immunology, Institute of Biomedicine, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Region Västra Götaland, Department of Clinical Pharmacology, Sahlgrenska University Hospital, Gothenburg, Sweden
| | - David Gyll
- Region Uppsala, Svartbäcken Primary Care, Uppsala, Sweden
| | - Jari Martikainen
- Bioinformatics and Data Centre, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
| | - Ailiana Santosa
- School of Public Health and Community Medicine, Institute of Medicine, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
| | - Huiqi Li
- School of Public Health and Community Medicine, Institute of Medicine, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
| | - Magnus Gisslén
- Department of Infectious Diseases, Institute of Biomedicine, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Region Västra Götaland, Department of Infectious Diseases, Sahlgrenska University Hospital, Gothenburg, Sweden
| | - Fredrik Nyberg
- School of Public Health and Community Medicine, Institute of Medicine, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
| |
Collapse
|
3
|
Spetz M, Lundberg L, Nwaru C, Li H, Santosa A, Ng N, Leach S, Gisslén M, Hammar N, Nyberg F, Rosvall M. An intersectional analysis of sociodemographic disparities in Covid-19 vaccination: A nationwide register-based study in Sweden. Vaccine 2022; 40:6640-6648. [PMID: 36210254 PMCID: PMC9515344 DOI: 10.1016/j.vaccine.2022.09.065] [Citation(s) in RCA: 12] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/09/2022] [Revised: 09/19/2022] [Accepted: 09/21/2022] [Indexed: 01/27/2023]
Abstract
BACKGROUND Studies on sociodemographic disparities in Covid-19 vaccination uptake in the general population are still limited and mostly focused on older adults. This study examined sociodemographic differences in Covid-19 vaccination uptake in the total Swedish population aged 18-64 years. METHODS National Swedish register data within the SCIFI-PEARL project were used to cross-sectionally investigate sociodemographic differences in Covid-19 vaccination among Swedish adults aged 18-64 years (n = 5,987,189) by 12 October 2021. Using logistic regression models, analyses were adjusted for sociodemographic factors, region of residence, history of Covid-19, and comorbidities. An intersectional analysis approach including several cross-classified subgroups was used to further address the complexity of sociodemographic disparities in vaccination uptake. FINDINGS By 12 October 2021, 76·0% of the Swedish population 18-64 years old had received at least two doses of Covid-19 vaccine, an additional 5·5% had received only one dose, and 18·5% were non-vaccinated. Non-vaccinated individuals were, compared to vaccinated, more often younger, male, had a lower income, were not gainfully employed, and/or were born outside Sweden. The social patterning for vaccine dose two was similar, but weaker, than for dose one. After multivariable adjustments, findings remained but were attenuated indicating the need to consider different sociodemographic factors simultaneously. The intersectional analysis showed a large variation in vaccine uptake ranging from 32% to 96% in cross-classified subgroups, reflecting considerable sociodemographic heterogeneity in vaccination coverage. INTERPRETATION Our study, addressing the entire Swedish population aged 18-64 years, showed broad sociodemographic disparities in Covid-19 vaccine uptake but also wide heterogeneities in coverage. The intersectional analysis approach indicates that focusing on specific sociodemographic factors in isolation and group average risks without considering the heterogeneity within such groups will risk missing the full variability of vaccine coverage. FUNDING SciLifeLab / Knut & Alice Wallenberg Foundation, Swedish Research Council, Swedish government ALF agreement, FORMAS.
Collapse
Affiliation(s)
- M. Spetz
- School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Sweden,Department of Clinical Microbiology, Sahlgrenska University Hospital, Region Västra Gotaland, Gothenburg, Sweden,Corresponding author at: School of Public health and Community Medicine, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Box 463, 405 30 Gothenburg, Sweden
| | - L. Lundberg
- Department of Microbiology and Immunology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden,Department of Clinical Pharmacology, Sahlgrenska University Hospital, Region Västra Götaland, Gothenburg, Sweden
| | - C. Nwaru
- School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Sweden
| | - H. Li
- School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Sweden
| | - A. Santosa
- School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Sweden
| | - N. Ng
- School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Sweden
| | - S. Leach
- Department of Microbiology and Immunology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden,Department of Clinical Pharmacology, Sahlgrenska University Hospital, Region Västra Götaland, Gothenburg, Sweden
| | - M. Gisslén
- Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden,Department of Infectious Diseases, Sahlgrenska University Hospital, Region Västra Götaland, Gothenburg, Sweden
| | - N. Hammar
- Unit of Epidemiology, Institute of Environmental Medicine, Karolinska Institute, Stockholm, Sweden
| | - F. Nyberg
- School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Sweden
| | - M. Rosvall
- School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Sweden,Department of Social Medicine, Regionhälsan, Region Västra Götaland, Gothenburg, Sweden
| |
Collapse
|
4
|
Lindquist S, Persson H, Roos A, Lundberg L, Hernell O. POS0434 A NOVEL TARGET FOR TREATMENT OF INFLAMMATORY JOINT DISEASES. Ann Rheum Dis 2022. [DOI: 10.1136/annrheumdis-2022-eular.3680] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
BackgroundA significant number of patients with inflammatory joint disorders do not respond or experience a waning effect to currently available pharmaceuticals, which emphasizes a high medical need for new efficacious drugs operating through novel targets and modes of action. One unexplored novel target is Bile Salt-Stimulated Lipase (BSSL).We have shown that patients with rheumatoid arthritis (RA), psoriasis arthritis (PsA), and juvenile idiopathic arthritis (JIA) have increased BSSL plasma levels compared to healthy controls, and that these levels correlate with disease activity scores. Moreover, conventional BSSL knockout mice are protected from developing disease in several recognized in vivo arthritis models and antibodies targeting BSSL prevent or mitigate arthritis in rodent models1.We have further shown that BSSL is secreted from activated granulocytes, binds to monocytes and stimulates their migration in vitro. With that knowledge, we developed a humanized anti-BSSL antibody (SOL-116) that blocks BSSL from binding to monocytes and we are now evaluating SOL-116 as candidate drug for treatment of chronic inflammatory joint diseases, including RA, PsA and JIA in man.ObjectivesThe aim of the present study was to characterize SOL-116’s biological activity in vitro and verify the therapeutic efficacy in the pristane induced arthritis (PIA) rat model.MethodsThe affinity of SOL-116 to human, mouse and rat BSSL was measured by surface plasmon resonance biosensor technology. The epitope on human BSSL was mapped by hydrogen deuterium exchange mass spectrometry (HDX-MS) and confirmed by crystallization of SOL-116 Fab-fragments with human BSSL. For efficacy evaluation, arthritis was induced in DA rats by administration of pristane. SOL-116 at three different doses (10, 30 and 90 mg/kg) or vehicle control were administered subcutaneously on day 5, 10 and 15 after disease induction. Disease activity was evaluated daily from day 7 in a blinded fashion using a macroscopic scoring system of the four limbs. To gain knowledge about the mechanism of action, the effect of SOL-116 on BSSL induced cell migration was evaluated using a transwell migration assay.ResultsSOL-116 binds to human, mouse, and rat BSSL, although a single amino acid deviation in the BSSL epitope results in approximately 80-fold lower affinity to rodent compared to human BSSL protein. In the efficacy validation study, treatment with highest dose SOL-116 (90 mg/kg) significantly mitigated disease severity in the PIA rats (Figure 1A). The relatively high doses of SOL-116 were chosen to compensate the low affinity for rat BSSL. A decrease in disease severity was also seen with SOL-116 at 30 mg/kg and 10 mg/kg, indicating a dose response, albeit not statistically significant. The plasma concentration of SOL-116 at day 19 correlated significantly to the arthritis score (Figure 1B). Mechanistic studies show that BSSL stimulates migration of CD14+ monocytes, and that SOL-116 prevents this effect in a dose dependent manner.Figure 1.Arthritis development and SOL-116 exposure in rats following pristane injection. (A) Animals treated with SOL-116 (90 mg/kg) show significantly lower disease severity compared to vehicle treated animals. Results are presented as mean ± SEM. (B) Plasma concentration of SOL-116 at day 19 in animals treated with 90 mg/kg correlates to disease severity.ConclusionThe present study verifies that BSSL plays an important role in inflammation and that SOL-116 is a promising biologic drug candidate for novel treatment of chronic inflammatory joint diseases.References[1]Lindquist S, Andersson EL, Lundberg L, Hernell O. Bile salt-stimulated lipase plays an unexpected role in arthritis development in rodents. PLoS One. 2012;7(10):e47006.AcknowledgementsThe authors are grateful to Mrs. Eva-Lotta Andersson for excellent technical assistance.Disclosure of InterestsSusanne Lindquist Shareholder of: Lipum AB, Umeå, Sweden, Grant/research support from: Lipum AB, Employee of: Lipum AB, Helena Persson: None declared, Annette Roos: None declared, Lennart Lundberg Shareholder of: Lipum AB, Consultant of: Lipum AB, Grant/research support from: Lipum AB, Employee of: Lipum AB, Olle Hernell Shareholder of: Lipum AB, Consultant of: Lipum AB, Grant/research support from: Lipum AB, Employee of: Lipum AB.
Collapse
|
5
|
Spetz M, Lundberg L, Nwaru C, Li H, Santosa A, Leach S, Gisslén M, Hammar N, Rosvall M, Nyberg F. The social patterning of Covid-19 vaccine uptake in older adults: A register-based cross-sectional study in Sweden. Lancet Reg Health Eur 2022; 15:100331. [PMID: 35252941 PMCID: PMC8881226 DOI: 10.1016/j.lanepe.2022.100331] [Citation(s) in RCA: 16] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
Abstract
Background Methods Findings Interpretation Funding
Collapse
|
6
|
Lundberg L, Bygdell M, Stukat von Feilitzen G, Woxenius S, Ohlsson C, Kindblom JM, Leach S. Recent MMR vaccination in health care workers and Covid-19: A test negative case-control study. Vaccine 2021; 39:4414-4418. [PMID: 34187707 PMCID: PMC8216866 DOI: 10.1016/j.vaccine.2021.06.045] [Citation(s) in RCA: 16] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/10/2021] [Revised: 06/14/2021] [Accepted: 06/18/2021] [Indexed: 01/06/2023]
Abstract
Background It has been hypothesised that the measles-mumps-rubella (MMR) vaccine may afford cross-protection against SARS-CoV-2 which may contribute to the wide variability in disease severity of Covid-19. Methods We employed a test negative case-control study, utilising a recent measles outbreak during which many healthcare workers received the MMR vaccine, to investigate the potential protective effect of MMR against SARS-CoV-2 in 5905 subjects (n = 805 males, n = 5100 females). Results The odds ratio for testing positive for SARS-CoV-2, in recently MMR-vaccinated compared to not recently MMR-vaccinated individuals was 0.91 (95% CI 0.76, 1.09). An interaction analysis showed a significant interaction for sex. After sex-stratification, the odds ratio for testing positive for males was 0.43 (95% CI 0.24, 0.79, P = 0.006), and 1.01 (95% CI 0.83, 1.22, P = 0.92) for females. Conclusion Our results indicate that there may be a protective effect of the MMR vaccine against SARS-CoV-2 in males but not females.
Collapse
Affiliation(s)
- Lisa Lundberg
- Dept. of Clinical Pharmacology, Sahlgrenska University Hospital, Gothenburg, Sweden
| | - Maria Bygdell
- Centre for Bone and Arthritis Research, Dept. of Internal Medicine and Clinical Nutrition, Inst. of Medicine, the Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden
| | | | - Susanne Woxenius
- Dept. of Infectious Diseases, Sahlgrenska University Hospital, Gothenburg, Sweden
| | - Claes Ohlsson
- Centre for Bone and Arthritis Research, Dept. of Internal Medicine and Clinical Nutrition, Inst. of Medicine, the Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden
| | - Jenny M Kindblom
- Centre for Bone and Arthritis Research, Dept. of Internal Medicine and Clinical Nutrition, Inst. of Medicine, the Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden; Pediatric Clinical Research Center, Sahlgrenska University Hospital, Gothenburg, Sweden
| | - Susannah Leach
- Dept. of Clinical Pharmacology, Sahlgrenska University Hospital, Gothenburg, Sweden; University of Gothenburg Vaccine Research Institute (GUVAX), Dept. of Microbiology and Immunology, Inst. of Biomedicine, the Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
| |
Collapse
|
7
|
Carlo‐Stella C, Hutchings M, Offner FC, Morschhauser F, Bachy E, Crump M, Sureda A, Iacoboni G, Haioun C, Perez‐Callejo D, Lundberg L, Relf J, Clark E, Carlile D, Piccione E, Belousov A, Humphrey K, Dickinson MJ. GLOFITAMAB STEP‐UP DOSING: UPDATED EFFICACY DATA SHOW HIGH COMPLETE RESPONSE RATES IN HEAVILY PRETREATED RELAPSED/REFRACTORY (R/R) NON‐HODGKIN LYMPHOMA (NHL) PATIENTS. Hematol Oncol 2021. [DOI: 10.1002/hon.15_2879] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
- C Carlo‐Stella
- Humanitas University and Humanitas Research Hospital Department of Biomedical Sciences Milan Italy
| | - M Hutchings
- Rigshospitalet Department of Hematology and Phase 1 Unit Copenhagen Denmark
| | - F. C Offner
- Universitair Ziekenhuis Gent Department of Hematology Gent Belgium
| | - F Morschhauser
- Hôpital Claude Huriez and Centre Hospitalier Régional Universitaire de Lille Department of Hematology Lille France
| | - E Bachy
- Hospices Civils de Lyon and Université Claude Bernard Department of Hematology Pierre‐Bénite France
| | - M Crump
- Princess Margaret Hospital Department of Medical Oncology Toronto Canada
| | - A Sureda
- Institut Català d'Oncologia Hospitalet IDIBELL, Universitat de Barcelona Department of Clinical Haematology Barcelona Spain
| | - G Iacoboni
- Vall d’Hebron University Hospital Department of Hematology Barcelona Spain
| | - C Haioun
- Hopital Henri Mondor, AP‐HP Lymphoid Malignancies Unit Créteil France
| | - D Perez‐Callejo
- N F. Hoffmann‐La Roche Ltd Clinical Science ‐ Product Development Hematology Basel Switzerland
| | - L Lundberg
- N F. Hoffmann‐La Roche Ltd Clinical Science ‐ Product Development Hematology Basel Switzerland
| | - J Relf
- Roche Products Ltd Clinical Safety ‐ Product Development Safety Welwyn Garden City UK
| | - E Clark
- Roche Products Ltd Product Development Biostatistics Welwyn Garden City UK
| | - D Carlile
- Roche Products Ltd Clinical Pharmacology, Pharma Research and Early Development Welwyn Garden City UK
| | - E Piccione
- Genentech, Inc Oncology Biomarker Development South San Francisco USA
| | - A Belousov
- F. Hoffmann‐La Roche Ltd Product Development Biostatistics Basel Switzerland
| | - K Humphrey
- Roche Products Ltd Clinical Science ‐ Product Development Hematology Welwyn Garden City UK
| | - M. J Dickinson
- The Peter MacCallum Cancer Centre Royal Melbourne Hospital and The University of Melbourne Clinical Haematology Melbourne Australia
| |
Collapse
|
8
|
Thiex NJ, Manson H, Anderson S, Persson JÅ, Anderson S, Bogren E, Bolek G, Budde D, Ellis C, Eriksson S, Field G, Frankenius E, Henderson C, Henry C, Kapphahn M, Lundberg L, Manson H, Moller J, Russell M, Sefert-Schwind J, Spann M. Determination of Crude Protein in Animal Feed, Forage, Grain, and Oilseeds by Using Block Digestion with a Copper Catalyst and Steam Distillation into Boric Acid: Collaborative Study. J AOAC Int 2019. [DOI: 10.1093/jaoac/85.2.309] [Citation(s) in RCA: 152] [Impact Index Per Article: 30.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
Abstract
Abstract
A collaborative study was conducted to evaluate the repeatability and reproducibility of an extension of AOAC Official Method 991.20, Nitrogen (Crude) in Milk, to animal feed, forage (plant tissue), grain, and oilseed materials. Test portions are digested in an aluminum block at 420°C in sulfuric acid with potassium sulfate and a copper catalyst. Digests are cooled and diluted, and concentrated sodium hydroxide is added to neutralize the acid and make the digest basic; the liberated ammonia is distilled by using steam distillation. The liberated ammonia is trapped in a weak boric acid solution and titrated with a stronger standardized acid, hydrochloric acid; colorimetric endpoint detection is used. Fourteen blind samples were sent to 13 collaborators in the United States, Denmark, Sweden, Germany, and the United Kingdom. Recoveries of nitrogen from lysine, tryptophan, and acetanilide were 86.8, 98.8, and 100.1%, respectively. The within-laboratory relative standard deviation (RSDr, repeatability) ranged from 0.40 to 2.38% for crude protein. The among-laboratories (including within-) relative standard deviation (RSDR, reproducibility) ranged from 0.44 to 2.38%. It is recommended that the method be adopted First Action by AOAC INTERNATIONAL. A lower concentration (1% H3BO3) of trapping solution was compared with the concentration specified in the original protocol (4% H3BO3) and was found comparable for use in an automatic titration system in which titration begins automatically as soon as distillation starts. The Study Directors recommend that 1% H3BO3 as an optional alternative to 4% boric acid trapping solution be allowed for automatic titrators that titrate throughout the distillation.
Collapse
Affiliation(s)
- Nancy J Thiex
- South Dakota State University, Oscar E. Olson Biochemistry Laboratories, Box 2170, ASC 151, Brookings, SD 57007
| | - Harold Manson
- South Dakota State University, Oscar E. Olson Biochemistry Laboratories, Box 2170, ASC 151, Brookings, SD 57007
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
9
|
Merino L, Edberg U, Fuchs G, Åman P, Corbari G, Dahlberg L, Da-Riz V, Eerola S, Gerard R, Grancher D, Jensen S, Kangro A, Kjolby A, Lundberg L, Marin M, Meland S, Muriel B, Nicolas M, Ravn T, Tuhkanen M, Vartiala T, Zieprath G. Liquid Chromatographic Determination of Residual Nitrite/Nitrate in Foods: NMKL Collaborative Study. J AOAC Int 2019. [DOI: 10.1093/jaoac/83.2.365] [Citation(s) in RCA: 27] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
Abstract
Nitrite and nitrate are used as additives in the food industry to provide color and taste and to control undesirable gas and flavor production by anaerobic bacteria by virtue of their antimicrobial properties. The analytical method that has been widely used to determine nitrite and nitrate involves the use of toxic cadmium. In response to a request from the Nordic Committee on Food Analysis, a study was performed to obtain an alternative chromatographic method to determine residual nitrite and nitrate in meat products. The study was done in 3 stages: (1) comparative evaluation of the performance of 3 liquid chromatographic methods, (2) internal validation of the selected ion chromatographic method, and (3) a collaborative study in which 17 laboratories from European countries participated. Furthermore, the applicability of the method to matrixes other than meat and meat products was demonstrated. The results of the collaborative study show that the European Prestandard prENV 12014-4 is well suited for the determination of nitrite and nitrate in different foods (e.g., meat products, vegetables, baby food, and cheese). The limits of detection for nitrite and nitrate ions are 1 and 10 mg/kg, respectively. Recoveries of residual nitrite/nitrate ranged from 96 to 108%. Repeatability and reproducibility were satisfactory.
Collapse
Affiliation(s)
- Leonardo Merino
- National Food Administration, Chemistry Division 2, PO Box 622, S-751 26 Uppsala, Sweden
| | - Ulla Edberg
- National Food Administration, Chemistry Division 2, PO Box 622, S-751 26 Uppsala, Sweden
| | - Georg Fuchs
- National Food Administration, Chemistry Division 2, PO Box 622, S-751 26 Uppsala, Sweden
| | - Per Åman
- Swedish University of Agricultural Sciences, Box 7051, S-750 07 Uppsala, Sweden
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
10
|
Arulandhu AJ, Staats M, Hagelaar R, Voorhuijzen MM, Prins TW, Scholtens I, Costessi A, Duijsings D, Rechenmann F, Gaspar FB, Barreto Crespo MT, Holst-Jensen A, Birck M, Burns M, Haynes E, Hochegger R, Klingl A, Lundberg L, Natale C, Niekamp H, Perri E, Barbante A, Rosec JP, Seyfarth R, Sovová T, Van Moorleghem C, van Ruth S, Peelen T, Kok E. Development and validation of a multi-locus DNA metabarcoding method to identify endangered species in complex samples. Gigascience 2018; 6:1-18. [PMID: 29020743 PMCID: PMC5632295 DOI: 10.1093/gigascience/gix080] [Citation(s) in RCA: 50] [Impact Index Per Article: 8.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/08/2017] [Accepted: 08/15/2017] [Indexed: 11/19/2022] Open
Abstract
DNA metabarcoding provides great potential for species identification in complex samples such as food supplements and traditional medicines. Such a method would aid Convention on International Trade in Endangered Species of Wild Fauna and Flora (CITES) enforcement officers to combat wildlife crime by preventing illegal trade of endangered plant and animal species. The objective of this research was to develop a multi-locus DNA metabarcoding method for forensic wildlife species identification and to evaluate the applicability and reproducibility of this approach across different laboratories. A DNA metabarcoding method was developed that makes use of 12 DNA barcode markers that have demonstrated universal applicability across a wide range of plant and animal taxa and that facilitate the identification of species in samples containing degraded DNA. The DNA metabarcoding method was developed based on Illumina MiSeq amplicon sequencing of well-defined experimental mixtures, for which a bioinformatics pipeline with user-friendly web-interface was developed. The performance of the DNA metabarcoding method was assessed in an international validation trial by 16 laboratories, in which the method was found to be highly reproducible and sensitive enough to identify species present in a mixture at 1% dry weight content. The advanced multi-locus DNA metabarcoding method assessed in this study provides reliable and detailed data on the composition of complex food products, including information on the presence of CITES-listed species. The method can provide improved resolution for species identification, while verifying species with multiple DNA barcodes contributes to an enhanced quality assurance.
Collapse
Affiliation(s)
- Alfred J Arulandhu
- RIKILT Wageningen University & Research, P.O. Box 230, 6700 AE Wageningen, The Netherlands.,Food Quality and Design Group, Wageningen University and Research, P.O. Box 8129, 6700 EV Wageningen, The Netherlands
| | - Martijn Staats
- RIKILT Wageningen University & Research, P.O. Box 230, 6700 AE Wageningen, The Netherlands
| | - Rico Hagelaar
- RIKILT Wageningen University & Research, P.O. Box 230, 6700 AE Wageningen, The Netherlands
| | - Marleen M Voorhuijzen
- RIKILT Wageningen University & Research, P.O. Box 230, 6700 AE Wageningen, The Netherlands
| | - Theo W Prins
- RIKILT Wageningen University & Research, P.O. Box 230, 6700 AE Wageningen, The Netherlands
| | - Ingrid Scholtens
- RIKILT Wageningen University & Research, P.O. Box 230, 6700 AE Wageningen, The Netherlands
| | | | - Danny Duijsings
- Baseclear B. V, Einsteinweg 5, 2333 CC Leiden, The Netherlands
| | - François Rechenmann
- GenoStar Bioinformatics Solutions, 60 rue Lavoisier, 38330 Montbonnot Saint Martin, France
| | - Frédéric B Gaspar
- iBET, Instituto de Biologia Experimental e Tecnológica, Apartado 12, 2780-901 Oeiras, Portugal
| | | | - Arne Holst-Jensen
- Norwegian Veterinary Institute, Ullevaalsveien 68, P.O. Box 750 Sentrum, 0106 Oslo, Norway
| | - Matthew Birck
- U.S. Customs and Border Protection Laboratory, 1100 Raymond Blvd Newark, NJ 07102 USA
| | - Malcolm Burns
- LGC, Queens Road, Teddington, Middlesex, TW11 0LY, UK
| | | | - Rupert Hochegger
- Austrian Agency for Health and Food Safety, Spargelfeldstrasse 191, 1220 Vienna, Austria
| | - Alexander Klingl
- Generalzolldirektion, Direktion IX, Bildungs- und Wissenschaftszentrum der Bundesfinanzverwaltung, Dienstort Hamburg, Baumacker 3, D-22523 Hamburg, Germany
| | - Lisa Lundberg
- Livsmedelsverket, Att. Lisa Lundberg, Strandbodgatan 4, SE 75323 Uppsala, Sweden
| | - Chiara Natale
- AGENZIA DELLE DOGANE E DEI MONOPOLI, Laboratori e servizi chimici - Laboratorio Chimico di Genova, 16126 Genova, Via Rubattino n. 6, Italy
| | - Hauke Niekamp
- Eurofins GeneScan GmbH, Engesserstrasse 4 79108 Freiburg, Germany
| | - Elena Perri
- CREA-SCS sede di Tavazzano - Laboratorio via Emilia, Km 307, 26838 Tavazzano, Italy
| | - Alessandra Barbante
- CREA-SCS sede di Tavazzano - Laboratorio via Emilia, Km 307, 26838 Tavazzano, Italy
| | - Jean-Philippe Rosec
- Service Commun des Laboratoires, Laboratoire de Montpellier, Parc Euromédecine, 205 rue de la Croix Verte, 34196 Montpellier Cedex 5, France
| | - Ralf Seyfarth
- Biolytix AG, Benkenstrasse 254, 4108 Witterswil, Switzerland
| | - Tereza Sovová
- Crop Research Institute, Department of Molecular Genetics, Drnovská 507, 161 06 Prague, Czech Republic
| | | | - Saskia van Ruth
- RIKILT Wageningen University & Research, P.O. Box 230, 6700 AE Wageningen, The Netherlands.,Food Quality and Design Group, Wageningen University and Research, P.O. Box 8129, 6700 EV Wageningen, The Netherlands
| | - Tamara Peelen
- Dutch Customs Laboratory, Kingsfordweg 1, 1043 GN, Amsterdam, The Netherlands
| | - Esther Kok
- RIKILT Wageningen University & Research, P.O. Box 230, 6700 AE Wageningen, The Netherlands
| |
Collapse
|
11
|
Stegmayr B, Esbensen K, Gutierrez A, Lundberg L, Nielsen B, Stroemsaeter CE, Wehle B. Granulocyte Elastase, β-Thromboglobulin, and C3D during Acetate or Bicarbonate Hemodialysis with Hemophan® Compared to a Cellulose Acetate Membrane. Int J Artif Organs 2018. [DOI: 10.1177/039139889201500103] [Citation(s) in RCA: 20] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
Twenty-two patients were dialysed in a cross-over design using Hemophan® or cellulose acetate membranes. The dialysate buffer was acetate (n = 12) or bicarbonate (n = 10). Blood was sampled at 0, 15, 60 and 180 min and mean values were adjusted for changes in total protein in each sample. At 15 min during dialysis a decrease in leukocytes and platelets occurred with both membranes, irrespective of the buffer (Wilcoxon, p < 0.006). During dialysis, increases were found in granulocyte elastase inhibitor complex (E-α1-PI), β-thromboglobulin and C3d. β2-microgrobulin was not significantly changed in blood after dialysis with Hemophan® or cellulose acetate membranes with bicarbonate buffer. Side effects were more pronounced at 180 min during dialysis with bicarbonate in patients using cellulose acetate than with Hemophan® (p = 0.021, n = 8). Hemophan® seemed to be more favourable than cellulose acetate membranes in regard to leukopenia and E- α1-PI. The dialysate buffer may also alter membrane biocompatibility.
Collapse
Affiliation(s)
- B.G. Stegmayr
- Division of Nephrology, Department of Internal Medicine, University Hospital, Umeå - Sweden
| | - K. Esbensen
- Department of Nephrology, Copenhagen University, Hvidovre Hospital - Denmark
| | - A. Gutierrez
- Department of Nephrology, Huddinge University Hospital, Stockholm - Sweden
| | - L. Lundberg
- Division of Nephrology, Department of Internal Medicine, University Hospital, Umeå - Sweden
| | - B. Nielsen
- Department of Nephrology, Copenhagen University, Hvidovre Hospital - Denmark
| | - C-E. Stroemsaeter
- Department of Internal Medicine, Oestfold County Hospital, Frederiksstad - Norway
| | - B. Wehle
- Department of Nephrology, Huddinge University Hospital, Stockholm - Sweden
| |
Collapse
|
12
|
Lundberg L, Stegmayr B, Wehle B. Backdiffusion or Bicarbonate May Stimulate Complement Activation during Haemodialysis with Low-Flux Membranes. Int J Artif Organs 2018. [DOI: 10.1177/039139889401700301] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Backdiffusion of dialysate during haemodialysis with low-flux membranes and the use of bicarbonate dialysatebase, may increase the risk for contamination. The influence on the complement system was studied by altering the flux of acetate or bicarbonate dialysate base across the membrane. Eight patients were dialysed with a transmembrane pressure of 100 mm Hg (group I) during the first 60 min to standardize the ultrafiltration (UF) and acetate as dialysate. In eight other patients (group II) the UF was “set at zero” ml during the first 60 min using an FCM 10-1 monitor (Gambro) and bicarbonate as base. The groups were dialysed three times on two hollow-fiber membranes made of Hemophan® and cellulose acetate (CA). Blood samples were taken at 0, 15, 60 and 180 min, and analysed for plasma protein, haematocrit and complement C3d. In group II there was a reduction in plasma protein concentration at 15 and 60 min (p<0.002) for Hemophan and at 60 min (p<0.01) using CA. C3d was increased at 15 min for both filters (p<0.03). The reduction of protein in group II was followed by changes in the haematocrit, indicating a backdiffusion of dialysate, which may contribute to the concomittant increase in C3d.
Collapse
Affiliation(s)
- L Lundberg
- Division of Nephrology, Department of Internal Medicine, University Hospital, Umeå - Sweden
| | - B.G. Stegmayr
- Division of Nephrology, Department of Internal Medicine, University Hospital, Umeå - Sweden
| | - B. Wehle
- Department of Nephrology, Huddinge University Hospital, Stockholm - Sweden
| |
Collapse
|
13
|
Steneberg P, Bernardo L, Edfalk S, Lundberg L, Backlund F, Östenson CG, Edlund H. The type 2 diabetes-associated gene ide is required for insulin secretion and suppression of α-synuclein levels in β-cells. Diabetes 2013; 62:2004-14. [PMID: 23349488 PMCID: PMC3661649 DOI: 10.2337/db12-1045] [Citation(s) in RCA: 79] [Impact Index Per Article: 7.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/24/2023]
Abstract
Genome-wide association studies have identified several type 2 diabetes (T2D) risk loci linked to impaired β-cell function. The identity and function of the causal genes in these susceptibility loci remain, however, elusive. The HHEX/IDE T2D locus is associated with decreased insulin secretion in response to oral glucose stimulation in humans. Here we have assessed β-cell function in Ide knockout (KO) mice. We find that glucose-stimulated insulin secretion (GSIS) is decreased in Ide KO mice due to impaired replenishment of the releasable pool of granules and that the Ide gene is haploinsufficient. We also show that autophagic flux and microtubule content are reduced in β-cells of Ide KO mice. One important cellular role for IDE involves the neutralization of amyloidogenic proteins, and we find that α-synuclein and IDE levels are inversely correlated in β-cells of Ide KO mice and T2D patients. Moreover, we provide evidence that both gain and loss of function of α-synuclein in β-cells in vivo impair not only GSIS but also autophagy. Together, these data identify the Ide gene as a regulator of GSIS, suggest a molecular mechanism for β-cell degeneration as a consequence of Ide deficiency, and corroborate and extend a previously established important role for α-synuclein in β-cell function.
Collapse
Affiliation(s)
- Pär Steneberg
- Umeå Center for Molecular Medicine, University of Umeå, Umeå, Sweden
| | - Lisandro Bernardo
- Umeå Center for Molecular Medicine, University of Umeå, Umeå, Sweden
| | - Sara Edfalk
- Umeå Center for Molecular Medicine, University of Umeå, Umeå, Sweden
| | - Lisa Lundberg
- Umeå Center for Molecular Medicine, University of Umeå, Umeå, Sweden
| | - Fredrik Backlund
- Umeå Center for Molecular Medicine, University of Umeå, Umeå, Sweden
| | - Claes-Göran Östenson
- Department of Molecular Medicine and Surgery, Endocrinology and Diabetology Unit, Karolinska Institutet, Karolinska University Hospital-Solna, Stockholm, Sweden
| | - Helena Edlund
- Umeå Center for Molecular Medicine, University of Umeå, Umeå, Sweden
- Corresponding author: Helena Edlund,
| |
Collapse
|
14
|
Gudjonsson S, Lövgren K, Fernö M, Bendahl P, Chebil G, Lundberg L, Lindgren D, Höglund M, Liedberg F, Monsson W. MP-20.16: EGFR Expression May Correlate with Prognosis in Non-Muscle Invasive Bladder Cancer. Urology 2009. [DOI: 10.1016/j.urology.2009.07.777] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
15
|
Jensen KA, Klaer I, Lundberg L. Studies on the antigenic structure of mycobacteria. 5. Acta Pathol Microbiol Scand 2009; 73:450-8. [PMID: 4971485 DOI: 10.1111/j.1699-0463.1968.tb04614.x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]
|
16
|
|
17
|
Stegmayr BG, Brännström M, Bucht S, Crougneau V, Dimeny E, Ekspong A, Eriksson M, Granroth B, Gröntoft KC, Hadimeri H, Holmberg B, Ingman B, Isaksson B, Johansson G, Lindberger K, Lundberg L, Mikaelsson L, Olausson E, Persson B, Stenlund H, Wikdahl AM. Low-dose atorvastatin in severe chronic kidney disease patients: A randomized, controlled endpoint study. ACTA ACUST UNITED AC 2009; 39:489-97. [DOI: 10.1080/00365590500329304] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Affiliation(s)
- B. G. Stegmayr
- Department of Internal Medicine, Division of Nephrology, University Hospital Umea, Umea, Sweden
| | | | - S. Bucht
- County Hospital of Sunderbyn, Sweden
| | - V. Crougneau
- Department of Internal Medicine, Division of Nephrology, University Hospital Umea, Umea, Sweden
| | - E. Dimeny
- Department of Internal Medicine, Division of Nephrology, University Hospital Umea, Umea, Sweden
| | | | - M. Eriksson
- Department of Internal Medicine, Division of Nephrology, University Hospital Umea, Umea, Sweden
| | | | | | | | - B. Holmberg
- Department of Internal Medicine, Division of Nephrology, University Hospital Umea, Umea, Sweden
| | - B. Ingman
- County Hospital of Sunderbyn, Sweden
| | | | | | | | - L. Lundberg
- Department of Internal Medicine, Division of Nephrology, University Hospital Umea, Umea, Sweden
| | | | | | | | - H. Stenlund
- Department of Internal Medicine, Division of Nephrology, University Hospital Umea, Umea, Sweden
| | | | | |
Collapse
|
18
|
|
19
|
Lundberg L, Jonsson A, Vikstrom T, Ruters A. Performance Indicators for Prehospital Command and Control Developed for Civilian Use Tested in a Military Training Setting, A Pilot Study. J ROY ARMY MED CORPS 2008; 154:236-8. [DOI: 10.1136/jramc-154-04-05] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
20
|
|
21
|
Lundberg L, Molde A, Dalenius E. BATLS/BARTS/BBTLS Training for Swedish Armed Forces Medical Personnel - A Ten Year Retrospective Study. J ROY ARMY MED CORPS 2008; 154:34-7. [DOI: 10.1136/jramc-154-01-10] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
22
|
Abstract
OBJECTIVE In order to train medical personnel properly for future international missions the Lithuanian Armed Forces decided to adopt BATLS/BARTS as a basic course for military pre-hospital trauma care. This decision was based upon the increasing Lithuanian participation in international missions as a part of multinational units. Another important reason was the personal experience of the course concept acquired in Sweden in 2001 by five Lithuanian medical officers. METHODS Similar to the way BATLS/BARTS was introduced in Sweden, a regular Swedish course (as given in Sweden for own units prior to international missions) was given in Lithuania. The faculty consisted of three experienced instructors from Sweden, and the two Lithuanian medical officers who had previously taken the BATLS course and the BATLS instructor course in Sweden. RESULTS Two BATLS/BARTS courses have been given in Kaunas, Lithuania. A total number of eight medical officers, nine military nurses, five medics, three civilian doctors and four medical students have taken the course. Some of these (four medical officers, two military nurses and two medics) have later been deployed to Afghanistan, Iraq and Kosovo, where the Lithuanian units have been collaborating with British, Danish, Polish and Czech-Slovakian units. CONCLUSION As international missions become multinational, it is essential there is full confidence in the level of training and preparedness among all units working together. One way to achieve this is through bi- or multinational training as described in this paper.
Collapse
Affiliation(s)
- A Molde
- Södersjukhuset, Stockholm, Sweden
| | | | | |
Collapse
|
23
|
Stegmayr BG, Brannstrom M, Bucht S, Dimeny E, Ekspong A, Granroth B, Grontoft KC, Hadimeri H, Holmberg B, Ingman B, Isaksson B, Johansson G, Lindberger K, Lundberg L, Lundstrom O, Mikaelsson L, Mortzell M, Olausson E, Persson B, Svensson L, Wikdahl AM. Minimized weight gain between hemodialysis contributes to a reduced risk of death. Int J Artif Organs 2006; 29:675-80. [PMID: 16874672 DOI: 10.1177/039139880602900705] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
UNLABELLED The risk of death is higher in dialysis patients compared to age matched healthy subjects, the main reason being cardiovascular. This prospective study investigated if the extent of ultrafiltration was of importance for the outcome. MATERIAL AND METHODS 88 hemodialysis patients were included and followed prospectively. The outcome was registered in regard to death, acute myocardial infarction or coronary vascular intervention. The extent of ultrafiltration needed at dialysis was calculated as a mean during the observation period as were other variables. The mean extent of ultrafiltration was compared for patients who had survived without end-points (group 1, n=53) versus those who reached any end-point during the period (group 2, n=35). RESULTS In total, 40% of the patients reached end-point during the observation period. There was no difference at baseline between the groups in regard to age, prevalence of diabetes mellitus or history of previous cardiovascular disease, KT/V, residual renal function ultrafiltration need, C-reactive protein, s-albumin, cholesterol, LDL-cholesterol, HDL-cholesterol, appetite or wellbeing, while triglyceride was lower in group 2 (p=0.035). The observation period for group 1 was at a mean 24.7 months (SD13.1) and for those in group 2 at a mean 13.8 (+/-11.7 months, p<0.001). Patients representing group 1 at 24 and 30 months had less need of ultrafiltration than those in group 2. Thus, the need of ultrafiltration was about 27% lower at 24 months (for 29 persons in group 1: 3.63+/-1.93 weight% versus 4.97+/-1.70 weight% for 9 patients from group 2, p=0.046) and 46% at 30 months (for 18 from group 1: 3.48+/-1.95 versus 6.45+/-1.55 for 3 from group 2, p=0.030). C-reactive protein did not differ significantly between the groups during the period. CONCLUSION After a prolonged period of 24 months the extent of ultrafiltration need seems to be important for the outcome of the patients. Thereby those with higher need of ultrafiltration had worse prognosis. It seems important to motivate patients to reduce the extent of fluid intake between dialysis to prolong survival.
Collapse
Affiliation(s)
- B G Stegmayr
- Division of Nephrology, Department of Internal Medicine, University Hospital, Umea, Sweden.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
24
|
Holmberg B, Brännström M, Bucht B, Crougneau V, Dimeny E, Ekspong A, Granroth B, Gröntoft KC, Hadimeri H, Ingman B, Isaksson B, Johansson G, Lindberger K, Lundberg L, Mikaelsson L, Olausson E, Persson B, Welin D, Wikdahl AM, Stegmayr BG. Safety and efficacy of atorvastatin in patients with severe renal dysfunction. ACTA ACUST UNITED AC 2006; 39:503-10. [PMID: 16303728 DOI: 10.1080/00365590510031255] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Abstract
OBJECTIVE To investigate the efficacy and safety of a daily dose of 10 mg of atorvastatin in patients with chronic kidney disease (CKD) stages 4 and 5 and a glomerular filtration rate of <30 ml/min. MATERIAL AND METHODS This was an open, prospective, randomized study. A total of 143 patients were included: 73 were controls and 70 were prescribed 10 mg/day of atorvastatin. As efficacy variables, total cholesterol, low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol and triglyceride levels were determined at the start of the study and at 1, 3, 6, 12, 18, 24, 30 and 36 months. RESULTS The follow-up period was a mean of 20+/-14.4 months (range 1-36 months) for those on atorvastatin versus 22+/-12.7 months (range 0.5-36 months) for the controls. Compared with baseline values, patients treated with atorvastatin had significantly lower concentrations of total cholesterol at Month 36 (5.8 vs 4.4 mmol/l; -23%; p<0.001), of LDL cholesterol at Month 36 (3.6 vs 2.2 mmol/l; -35%; p<0.001) and of triglycerides at Months 24 (2.5 vs 1.9 mmol/l) and 36 (2.5 vs 1.8 mmol/l). The controls had significantly reduced levels of total cholesterol at Month 36 (p<0.21) and of LDL cholesterol at Months 30 and 36. Compared with the controls, the atorvastatin group had lower levels of total cholesterol and LDL cholesterol at Months 1-30. Fifteen patients (21%) stopped taking their medication as they could not tolerate the side-effects, the most frequent complaints being gastrointestinal discomfort and headache. CONCLUSION Although the medication caused no severe adverse events, we recommend caution when using atorvastatin for severe CKD patients until further evidence of its safety and efficacy is verified.
Collapse
Affiliation(s)
- B Holmberg
- Department of Internal Medicine, Divisions of Nephrology, Umeå Hospital, Umeå, Sweden
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
25
|
Sandberg M, Lundberg L, Ferm M, Malmheden Yman I. Real Time PCR for the detection and discrimination of cereal contamination in gluten free foods. Eur Food Res Technol 2003. [DOI: 10.1007/s00217-003-0758-4] [Citation(s) in RCA: 70] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
26
|
Strömberg L, Lundberg L, Neumann H, Bobon B, Huizer H, van der Stelt NW. Heroin impurity profiling. A harmonization study for retrospective comparisons. Forensic Sci Int 2000; 114:67-88. [PMID: 10967248 DOI: 10.1016/s0379-0738(00)00295-4] [Citation(s) in RCA: 39] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
Three laboratories present a harmonised system for the retrospective comparison of south west Asian heroin. It consists of an improved gas chromatographic (GC) profiling method and a computerised data retrieval. The investigations of the GC were necessary with a view to improve the reproducibility of the system. The necessity of a strict quality control is emphasized. The peaks of the GC profile were investigated for abundance, intensity, GC behaviour (reproducibility) and correlations; 16 of them were selected for describing the heroin profile in the database. The results from intra-lab profile comparisons are reported. The reproducibility of the analysis was good and the variation between the samples was large, thus, allowing conclusions with a high degree of certainty. The criteria of similarity were defined. The system is successfully running in all three labs. In connection with inter-laboratory comparison, the aspects of method harmonisation and standardisation are discussed. It appeared that the GC method is a very subtile one, urging for a strict standardisation between the three labs. Despite a long cooperation between three well-equipped and experienced labs, a more or less serious loss of reproducibility was noticed in the inter-lab results in comparison with the intra-lab results. The loss could for the greater part be attributed to the (limits of the) GC technique; a number of compounds, necessary for making the discrimination between samples, showed difficult chromatographic behaviour, leading to insufficient inter-lab reproducibility. Using the actual variables, improvements in performance can hardly be expected in the near future. The loss of reproducibilty implies that the number of false positive matches in a database search increases. This may strongly reduce the value of a relatively large, international database. The study shows that so far, the best option for international comparison is the analysis in a central laboratory. The idea of local determination at a large number of national labs and the use of a common database is not a realistic aim for this type of analysis.
Collapse
Affiliation(s)
- L Strömberg
- National Laboratory of Forensic Science, S-581 94, Linköping, Sweden
| | | | | | | | | | | |
Collapse
|
27
|
Lundberg L, Johannesson M, Silverdahl M, Hermansson C, Lindberg M. Health-related quality of life in patients with psoriasis and atopic dermatitis measured with SF-36, DLQI and a subjective measure of disease activity. Acta Derm Venereol 2000; 80:430-4. [PMID: 11243637 DOI: 10.1080/000155500300012873] [Citation(s) in RCA: 161] [Impact Index Per Article: 6.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022] Open
Abstract
The impact of skin diseases on health-related quality of life is considerable. It is important to quantify the patient's perspective of the severity of their disease. Health-related quality of life was measured in 366 patients with skin diseases attending the dermatology outpatient clinic in Uppsala, Sweden, from November 1996 to December 1997, with 1 generic (SF-36) and 1 disease-specific (DLQI) health-related quality of life instrument, and a subjective measure of disease activity. The SF-36 mean scores were below those of the age- and gender-matched general population in Sweden. No difference in health-related quality of life was found between men and women or between patients with atopic dermatitis and psoriatic patients. However, patients with psoriatic arthritis had significantly poorer health-related quality of life than both patients with atopic dermatitis and psoriatic patients. The estimated correlations between the instruments were in the expected direction and mostly significant. The results confirm that skin diseases have an adverse impact on patients' health-related quality of life.
Collapse
Affiliation(s)
- L Lundberg
- Department of Pharmacy, Pharmaceutical Services Research, Unit of Biomedical Ethics, Uppsala University, Sweden
| | | | | | | | | |
Collapse
|
28
|
Lundberg L, Johannesson M, Silverdahl M, Hermansson C, Lindberg M. Quality of life, health-state utilities and willingness to pay in patients with psoriasis and atopic eczema. Br J Dermatol 1999; 141:1067-75. [PMID: 10606854 DOI: 10.1046/j.1365-2133.1999.03207.x] [Citation(s) in RCA: 147] [Impact Index Per Article: 5.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
Skin diseases have been shown to have a significant adverse impact on the health-related quality of life of patients that may be underestimated by objective assessments of clinical severity. The main aim of this study was to measure the health-state utilities on a scale between 0 (dead) and 1 (full health) of patients with psoriasis and atopic eczema, and to measure the willingness to pay for a cure for psoriasis and atopic eczema. A second aim was to analyse how these measures are related to different dimensions of health-related quality of life, as measured by general and disease-specific quality of life instruments and a subjective measure of disability activity. This study was based on data from a questionnaire administered to, and interviews conducted with, 366 patients with psoriasis and atopic eczema aged 17-73 years, attending the dermatology outpatient clinic in Uppsala, Sweden from November 1996 to December 1997. The survey included: a rating scale question, a time trade-off question, a standard gamble question, a dichotomous choice willingness to pay question, a bidding-game willingness to pay question, a generic quality of life instrument (SF-36), a disease-specific quality of life instrument (the Dermatology Life Quality Index) and a subjective measure of disease activity (on a visual analogue scale). The mean health-state utility was 0.69 (rating scale), 0.88 (time trade-off) and 0.97 (standard gamble) for patients with psoriasis. The corresponding health-state utilities for patients with atopic eczema were 0.73, 0.93 and 0.98. On average, patients were willing to pay between 1253 and 1956 Swedish crowns (SEK) per month for a psoriasis cure and between SEK 960 and 1083 per month for an atopic eczema cure ($1 = SEK 8.25 and pound1 = SEK 13.23). The health-state utilities were related to SF-36, the Dermatology Life Quality Index and disease activity in the expected direction and the correlations were strongest for rating scale and weakest for standard gamble. The willingness to pay was correlated with the Dermatology Life Quality Index and disease activity, but not with SF-36. The study indicates that it is feasible to measure health-state utilities and willingness to pay in this patient population, and the sizeable willingness to pay suggests that skin diseases are associated with substantial reductions in quality of life.
Collapse
Affiliation(s)
- L Lundberg
- Department of Pharmacy, Pharmaceutical Services Research, BMC, Uppsala University, Sweden.
| | | | | | | | | |
Collapse
|
29
|
Lundberg L. Methodology. Health-state utilities in a general population in relation to age, gender and socioeconomic factors. Eur J Public Health 1999. [DOI: 10.1093/eurpub/9.3.211] [Citation(s) in RCA: 42] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
30
|
Abstract
As compared with 580 randomly chosen pregnant women without malformed offspring. 161 women with malformed offspring at the index pregnancy had a more frequent history of previous multiple offspring deaths and somewhat increased maternal age but were not different on social class, marital or cohabitation status or parity. As compared with demographically similar reproducing women (n = 54) interviewed, malformation cases (n = 98) reported having had significantly more strong stress before identification of the malformation, as well as a clear tendency toward less appropriate timing of the pregnancy. Women with malformed offspring represent a psychosocially vulnerable group and should receive special clinical and personal support.
Collapse
Affiliation(s)
- G T Nimby
- Department of Psychiatry, Lund University, Malmö University Hospital MAS, Sweden.
| | | | | | | |
Collapse
|
31
|
Abstract
It would be a major advance if quality-of-life instruments could be translated into health-state utilities. The aim with this study was to investigate the relationship between the SF-12 and health-state utilities, based on responses to a postal questionnaire sent to a random sample of 8,000 inhabitants, aged 20-84 years, in the general population. The questionnaire included the SF-12, a rating-scale (RS) question, and a time-tradeoff (TTO) question; the response rate was 68%. Age, gender, and the 12 items of the SF-12 were used as explanatory variables in a linear regression analysis of the health-state utilities. The regression models explained about 50% of the variance in the RS answers and about 25% of the variance in the TTO answers. Most of the SF-12 items were related to the health-state utilities in the expected ways, with especially strong results for the RS method. The results suggest that the SF-12 can be converted to health-state utilities, but that further work is needed to reliably estimate the conversion function.
Collapse
Affiliation(s)
- L Lundberg
- Department of Pharmacy, Uppsala University, Sweden.
| | | | | | | |
Collapse
|
32
|
Abstract
OBJECTIVE The aim was to study changes in sales and prescribing of nasal decongestants containing oxymetazoline or xylometazoline, changes in number of physician visits for rhinitis and sinusitis, and changes in public expenditures for physician visits due to the switch of these drugs from prescription to over-the-counter status in Sweden in 1989. DESIGN Retrospective registry study using the local sales statistics on medicines in the municipality of Tierp from The National Corporation of Swedish Pharmacies and the individual-based computerised registry in Tierp based on health care utilisation and drug use from the Centre for Primary Care. Analyses were carried out during the time period 1988-1995. SETTING The Swedish community of Tierp with about 20,000 inhabitants. SUBJECTS The population of Tierp. MAIN OUTCOME MEASURE Sales of nasal decongestants and dispensed prescriptions of nasal decongestants, physician visits for rhinitis and sinusitis, and public expenditures for these. RESULTS Sales of nasal sprays increased, while sales of nasal drops decreased. The number of dispensed prescriptions as well as physician visits decreased. The public expenditures estimated for physician visits decreased as well. CONCLUSION This study shows an increase in sales of nasal decongestants and a significant decrease in prescribing of nasal decongestants and the number of physician visits for rhinitis and sinusitis as well as the public expenditures estimated for these, after the switch from prescription to over-the counter status of nasal sprays in 1989.
Collapse
Affiliation(s)
- L Lundberg
- Department of Pharmacy, Uppsala University, Sweden
| | | |
Collapse
|
33
|
Gerdtham UG, Johannesson M, Lundberg L, Isacson D. A note on validating Wagstaff and van Doorslaer's health measure in the analysis of inequalities in health. J Health Econ 1999; 18:117-124. [PMID: 10338817 DOI: 10.1016/s0167-6296(98)00041-1] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/23/2023]
Abstract
The aim of this note is to validate Wagstaff and van Doorslaer's approach of constructing a continuous health measure to be used in the analysis of inequalities in health. We calculate health concentration indices for Uppsala County in Sweden based on three different health status measures: health measured according to the WvD approach based on a self-assessed categorical health measure, health measured by the rating scale method, and health measured by the time trade-off method. The concentration index does not differ significantly for the three health status measures, and our results thus support the validity of the WvD method.
Collapse
Affiliation(s)
- U G Gerdtham
- Department of Economics, Stockholm School of Economics, Sweden.
| | | | | | | |
Collapse
|
34
|
Abstract
This study examined the sensitivity towards increases in user charges for different types of drugs and among different socio-economic groups. It was based on responses by 2008 consumers of prescription drugs to a self-administered postal questionnaire sent to a random sample of 8000 inhabitants in Uppsala County in Sweden. The questionnaire included a question about whether the respondents would use fewer prescription drugs if the user charges increased by a specific amount. The increase in user charges was varied between 9 and 150% in five different subsamples. Logistic regression analysis was used to estimate the probability that a respondent would reduce consumption of prescription drugs as a function of the size of the user charges increase, socio-economic characteristics and the type of drug used. Results showed that the price sensitivity decreased with increasing age, income, education and self-rated health status. Price sensitivity was highest for antitussives and lowest for climacteric drugs. If the user charges doubled, 40% of antitussives users would reduce their consumption whereas only 11% of climacteric drugs users would reduce their consumption. It is concluded that sensitivity to increases in user charges varied greatly between different types of drugs and between socio-economic groups. The young, those with poor health status, low education and low income are most likely to decrease consumption of prescription drugs when user charges increase.
Collapse
|
35
|
Strömqvist M, Hernell O, Hansson L, Lindgren K, Skytt A, Lundberg L, Lidmer AS, Bläckberg L. Naturally occurring variants of human milk bile salt-stimulated lipase. Arch Biochem Biophys 1997; 347:30-6. [PMID: 9344461 DOI: 10.1006/abbi.1997.0307] [Citation(s) in RCA: 21] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
Analysis of milk samples from a number of lactating women revealed molecular variants of bile salt-stimulated lipase (BSSL) of both lower and higher molecular mass than that commonly occurring. In contrast to previous observations, we report on individuals having only a variant of lower mass, both one of lower and one of common mass, or both one of lower and one of higher mass of the lipase. From two individuals we purified the lower molecular mass BSSL variant and characterized it. The amount of lipase in the milk of these two individuals was considerably less than average (mean of 10 women with BSSL of the most common molecular mass). The BSSL variant of lower mass showed the same bile salt activation, pH dependency, temperature stability as those most commonly occurring. We could localize the difference in mass to the large O-glycosylated repeat sequence close to the C-terminus of the protein. With respect to all characteristics studied, the BSSL variant of higher mass was also similar to that most commonly ocurring. Again, the difference in mass could be localized to the repeat region of the protein. Hence, it appears as if the repeat region, normally carrying 16 repeats of 11 amino acids each, varies in size between individuals.
Collapse
Affiliation(s)
- M Strömqvist
- Astra Hässle AB, Tvistevägen 48, Umeâ, S-907 36, Sweden.
| | | | | | | | | | | | | | | |
Collapse
|
36
|
Crider BP, Andersen P, White AE, Zhou Z, Li X, Mattsson JP, Lundberg L, Keeling DJ, Xie XS, Stone DK, Peng SB. Subunit G of the vacuolar proton pump. Molecular characterization and functional expression. J Biol Chem 1997; 272:10721-8. [PMID: 9099722 DOI: 10.1074/jbc.272.16.10721] [Citation(s) in RCA: 45] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023] Open
Abstract
The vacuolar type proton pump of clathrin-coated vesicles has a multisubunit ATP hydrolytic center that is peripheral to the membrane. Polypeptides present in this domain include the well characterized subunits A, B, C, D, E, and F; SFD, a dimer composed of 50- and 57-kDa polypeptides; and polypeptides termed G and H. Of these, subunits A, B, C, and E have been shown to be necessary but not sufficient for significant ATPase activity; in addition, either polypeptide G or H is also required for ATP hydrolysis (Xie, X.-S. (1996) J. Biol. Chem. 271, 30980-30985). In this study, the polypeptides G and H were purified and directly sequenced. Subsequent molecular analysis has revealed that these proteins are isoforms, which we designate G1 and G2. The cDNAs encoding the rat and bovine brain and chicken osteoclast forms of G1 have been cloned. The open reading frames of the rat and bovine clones encode hydrophilic proteins of 118 amino acids that differ at only five residues; bovine G1 has 36% identity with VMA10, a component of the proton channel of yeast. Northern blot analysis revealed a 1. 0-kilobase pair transcript encoding G1 in bovine brain, kidney, heart, and spleen. The cDNA encoding bovine polypeptide H was cloned and sequenced, revealing this protein to be 64% identical to G1, constituting isoform G2. In Northern blot analysis, a single 1. 7-kilobase pair transcript hybridized with a probe to G2 in brain, but not in heart, kidney, or spleen. An antibody against a bovine G1-specific domain reacts with V pump from bovine brain, kidney, and chromaffin granule, whereas an anti-G2 antibody reacts only with proton pump from brain. The bovine forms of G1 and G2 were subsequently expressed in Escherichia coli and Sf9 cells, respectively, and purified to homogeneity. Reconstitution of ATP hydrolysis was achieved by combination of recombinant subunits A, B, C, and E with either recombinant G1 or G2, demonstrating the role of these isoforms in pump function.
Collapse
Affiliation(s)
- B P Crider
- Division of Molecular Transport, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas 75235-9121, USA
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
37
|
Strömqvist M, Törnell J, Edlund M, Edlund A, Johansson T, Lindgren K, Lundberg L, Hansson L. Recombinant human bile salt-stimulated lipase: an example of defective O-glycosylation of a protein produced in milk of transgenic mice. Transgenic Res 1996; 5:475-85. [PMID: 8840531 DOI: 10.1007/bf01980213] [Citation(s) in RCA: 19] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
Abstract
The expression of recombinant human bile salt-stimulated lipase (bssl) was targeted to the lactating mammary gland of transgenic mice. Expression of recombinant genes comprising bsslcDNA, or alternatively genomic bssl DNA, under control of regulatory elements derived from the murine whey acidic protein (wap) gene was achieved and evaluated. Constructs containing genomic bssl sequences mediated high levels (0.5-1 mg ml-1) of recombinant human BSSL in the milk. The recombinant BSSL produced was purified, biochemically characterized and compared to native BSSL and recombinant BSSL produced in mouse C127 and hamster CHO cells. Recombinant BSSL derived from transgenic mice showed a different migration and distribution after SDS-PAGE electrophoresis, lower apparent molecular mass on size-exclusion chromatography and no detectable interactions with a panel of lectins. These results indicate a significantly lower degree of O-glycosylation of recombinant BSSL in milk from transgenic mice than was found for the native enzyme or recombinant CHO- or C127 cell-produced BSSL. Despite these differences, mouse-milk-derived recombinant BSSL exhibited similar lipase activity, the same stability to low pH and similar sensitivity to elevated temperatures as the native enzyme. The observation that mouse-C127-cell-produced recombinant BSSL is heavily O-glycosylated makes species-related restrictions less attractive as an explanation for the reduced O-glycosylation.
Collapse
|
38
|
Lundberg L, Olsson JO, Kihl B. Long-term experience of self-injection therapy with prostaglandin E1 for erectile dysfunction. Scand J Urol Nephrol 1996; 30:395-7. [PMID: 8936629 DOI: 10.3109/00365599609181316] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Abstract
A total of 42 evaluable patients 36-80 years old were treated with intracavernous injection of prostaglandin E1 for erectile dysfunction. They reported retrospectively via a questionnaire their long-term experience of this method. Twenty-four patients (57%) were after 46.9 months still using the technique, while 18 patients (43%) had abandoned the method after 21.4 months of use. No major complications were observed or reported.
Collapse
Affiliation(s)
- L Lundberg
- Section of Urology, Department of Surgery, Central Hospital, Karlstad, Sweden
| | | | | |
Collapse
|
39
|
Lundberg L, Stenberg B, Jansson JF. Relaxation of Segmental Orientation and Chain Extension in Polycarbonate Studied by Infrared Dichroism and Shrinkage. Macromolecules 1996. [DOI: 10.1021/ma9464433] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- L. Lundberg
- Department of Polymer Technology, Royal Institute of Technology, S-100 44 Stockholm, Sweden
| | - B. Stenberg
- Department of Polymer Technology, Royal Institute of Technology, S-100 44 Stockholm, Sweden
| | - J.-F. Jansson
- Department of Polymer Technology, Royal Institute of Technology, S-100 44 Stockholm, Sweden
| |
Collapse
|
40
|
Lundberg L, Jansson JF. Influence of physical ageing on the non-linear viscoelasticity of polycarbonate. POLYMER 1996. [DOI: 10.1016/0032-3861(96)81126-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
41
|
Lidmer AS, Kannius M, Lundberg L, Bjursell G, Nilsson J. Molecular cloning and characterization of the mouse carboxyl ester lipase gene and evidence for expression in the lactating mammary gland. Genomics 1995; 29:115-22. [PMID: 8530060 DOI: 10.1006/geno.1995.1221] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/31/2023]
Abstract
DNA hybridization was used to isolate a 2.04-kb cDNA encoding carboxyl ester lipase (CEL) from a mouse lactating mammary gland, lambda gt10 cDNA library. The cDNA sequence translated into a protein of 599 amino acids, including 20 amino acids of a putative signal peptide. Comparison of the deduced amino acid sequence of the mouse CEL with CEL from five other species revealed that there is a high degree of homology between the different species. The mouse CEL gene was also isolated and found to span approximately 7.2 kb and to include 11 exons. This organization is similar to those of the recently reported human and rat CEL genes. We have also analyzed expression of the CEL gene in the mammary glands from other species by performing a Northern blot analysis with RNA from goat and cow. The results show that the gene is expressed in both species.
Collapse
Affiliation(s)
- A S Lidmer
- Department of Molecular Biology, Göteborg University, Medicinaregatan 9C, S-413 90 Göteborg, Sweden; Astra Hässle AB, Mölndal, Sweden
| | | | | | | | | |
Collapse
|
42
|
Bläckberg L, Strömqvist M, Edlund M, Juneblad K, Lundberg L, Hansson L, Hernell O. Recombinant human-milk bile-salt-stimulated lipase. Functional properties are retained in the absence of glycosylation and the unique proline-rich repeats. Eur J Biochem 1995; 228:817-21. [PMID: 7737181 DOI: 10.1111/j.1432-1033.1995.tb20327.x] [Citation(s) in RCA: 22] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
Abstract
Human milk bile-salt-stimulated lipase ensures efficient utilization of milk lipid in breast-fed infants. The N-terminal two-thirds of the peptide chain is highly conserved and shows striking similarities to typical esterases. In contrast, the remaining C-terminal part consists of a unique sequence of 16 proline-rich O-glycosylated repeats of 11 residues each. Recently we could show, using recombinant lipase variants, that neither these repeats nor the single N-linked sugar chain are essential for catalytic efficiency. In the present study, we report on the lack of importance of glycosylation and the unique repeats for other important functional properties, i.e. bile-salt activation, heparin binding, heat stability, stability at low pH and resistance to proteolytic inactivation. Compared to native enzyme, recombinant full-length lipase produced in two mammalian cell lines differed slightly in glycosylation pattern with no effects on the functional properties. Moreover, a variant lacking all repeats and the C-terminal tail following the last repeat exhibited the same functional characteristics as purified native milk enzyme. Thus, the structural basis for all the typical and functionally important properties reside in the N-terminal conserved part, in spite of the fact that none of these properties are shared by typical esterases. We could however, demonstrate that the C-terminal repeats are responsible for the unusual behaviour of the enzyme in size-exclusion chromatography, resulting in a considerably higher than expected apparent molecular mass.
Collapse
Affiliation(s)
- L Bläckberg
- Department of Medical Biochemistry and Biophysics, Umeå University, Sweden
| | | | | | | | | | | | | |
Collapse
|
43
|
Lindqvist B, Lundberg L, Wieslander J. The prevalence of circulating anti-tubular basement membrane-antibody in renal diseases, and clinical observations. Clin Nephrol 1994; 41:199-204. [PMID: 8026111] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023] Open
Abstract
Anti-tubular basement membrane antibodies were determined by ELISA in 217 patients with different renal diseases. The assay for antibodies in serum was based on a 58 kD bovine tubular basement membrane antigen. Sera were studied from 69 patients with different forms of interstitial nephritis; 15 patients (10 women, 5 men) had anti-tubular basement membrane titers above the normal (compared with a reference group of healthy blood donors). Three patients are presented in greater detail. Thirty-four patients with pyelonephritis (confirmed by intravenous urogram) were investigated; one serum was positive. Sera from 114 patients with renal glomerular and/or vascular disease were studied; 12 had positive titers for tubular basement membrane and glomerular basement membrane or other kidney disease antibodies. This study supports the opinion that damage in the renal medulla can be caused by an autoimmune process. Circulating anti-TBM antibodies may be of value in the investigation of patients with tubulo-interstitial diseases but the cause and prognosis of this condition is, however, not known.
Collapse
Affiliation(s)
- B Lindqvist
- Department of Medicine, Umeå University Hospital, Sweden
| | | | | |
Collapse
|
44
|
Lundberg L, Stegmayr BG, Wehle B. Backdiffusion or bicarbonate may stimulate complement activation during haemodialysis with low-flux membranes. Int J Artif Organs 1994; 17:131-6. [PMID: 8050803] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
Abstract
Backdiffusion of dialysate during haemodialysis with low-flux membranes and the use of bicarbonate dialysatebase, may increase the risk for contamination. The influence on the complement system was studied by altering the flux of acetate or bicarbonate dialysate base across the membrane. Eight patients were dialysed with a transmembrane pressure of 100 mm Hg (group I) during the first 60 min to standardize the ultrafiltration (UF) and acetate as dialysate. In eight other patients (group II) the UF was "set at zero" ml during the first 60 min using an FCM 10-1 monitor (Gambro) and bicarbonate as base. The groups were dialysed three times on two hollow-fiber membranes made of Hemophan and cellulose acetate (CA). Blood samples were taken at 0, 15, 60 and 180 min, and analysed for plasma protein, haematocrit and complement C3d. In group II there was a reduction in plasma protein concentration at 15 and 60 min (p < 0.002) for Hemophan and at 60 min (p < 0.01) using CA. C3d was increased at 15 min for both filters (p < 0.03). The reduction of protein in group II was followed by changes in the haematocrit, indicating a backdiffusion of dialysate, which may contribute to the concomittant increase in C3d.
Collapse
Affiliation(s)
- L Lundberg
- Department of Internal Medicine, University Hospital, Umeå, Sweden
| | | | | |
Collapse
|
45
|
Hansson L, Bläckberg L, Edlund M, Lundberg L, Strömqvist M, Hernell O. Recombinant human milk bile salt-stimulated lipase. Catalytic activity is retained in the absence of glycosylation and the unique proline-rich repeats. J Biol Chem 1993; 268:26692-8. [PMID: 8253803] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/29/2023] Open
Abstract
Human milk bile salt-stimulated lipase ensures efficient utilization of triacylglycerol by breast-fed infants. Cloning and sequencing of cDNA have revealed that the peptide chain consists of 722 amino acid residues showing only little homology to typical lipases. The sequence is identical to that of pancreatic carboxylic-ester hydrolase. The COOH-terminal part contains 16 proline-rich repeats of 11 residues with O-linked carbohydrate. The only N-linked sugar chain is situated close to the active-site serine. Using C127 cells and a bovine papilloma virus vector, high and stable expression of full-length lipase and of several variants, obtained by site-directed mutagenesis, was achieved. The produced proteins were purified and further characterized. Variants lacking all, or all but two, repeats were active with similar specific activity and the same bile salt dependence as the native milk enzyme. Changing the asparagine necessary for N-glycosylation gave the same principal results. Active recombinant full-length lipase was also produced in a bacterial system. We conclude that neither glycosylation (N- or O-linked) nor the proline-rich repeats are essential for catalytic activity or bile salt activation of human milk bile salt-stimulated lipase.
Collapse
|
46
|
Hansson L, Bläckberg L, Edlund M, Lundberg L, Strömqvist M, Hernell O. Recombinant human milk bile salt-stimulated lipase. Catalytic activity is retained in the absence of glycosylation and the unique proline-rich repeats. J Biol Chem 1993. [DOI: 10.1016/s0021-9258(19)74368-3] [Citation(s) in RCA: 35] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
|
47
|
Sompolinsky D, Katzenstein T, Lundberg L. Circulatory basophilia in guinea pigs with delayed-type hypersensitivity. Topical antigenic provocation induces circulatory basophilia. Allergy 1992; 47:303-8. [PMID: 1443449 DOI: 10.1111/j.1398-9995.1992.tb02058.x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
Abstract
Circulatory basophilia could be induced in inbred guinea pigs systematically immunized with ovalbumin and consequently provoked repeatedly with dissolved ovalbumin applied onto the mucosa of the nares or the outer eye. The degree of the increase in circulatory basophil granulocytes depended on the adjuvant used and was significantly more pronounced after immunization with Freund's complete adjuvant than with alhydrogel (Al(OH)3). The degree of basophilia was also dependent on the animal strain, but different in two strains selected for high-asthma trait.
Collapse
Affiliation(s)
- D Sompolinsky
- Institute of Medical Microbiology, University of Copenhagen, Denmark
| | | | | |
Collapse
|
48
|
Abstract
A single conjunctival application of ovalbumin to inbred guinea pigs (IMM/S 209) immunized with the same antigen in Freund's complete adjuvant provoked an acute purulent inflammation of the anterior segment of the eyes with a duration of up to 1 week. Intense conjunctival injection and chemosis were followed by a purulent discharge. A corneal haze was observed regularly, and a considerable proportion of the animals developed a pronounced pannus and corneal ulcers. Tear fluid cytology revealed a rapid increase in cell concentration, from the normal level (less than 10(8)/l) to greater than 10(11)/l. Seventy to 95% of the cells were polymorphonuclear leukocytes. Histological examination revealed an acute inflammatory reaction which radiated from the conjunctival fornices to the entire anterior segments of the eyes. The process was characterized by an intense oedema, vasodilation and perivascular aggregations of polymorphonuclear leukocytes, and to a lesser extent eosinophilic granulocytes which characteristically infiltrated and penetrated the epithelial layers. Neovascularization could be observed early after challenge in the stroma of all parts of the outer eye. Ulcerations of the conjunctival and corneal epithelia were observed frequently. After a number of reiterations of the antigenic challenge, a marked infiltration with lymphocytes and basophils/mast cells was observed, and significant scarring of the conjunctival mucosa developed. In several animals, a slight, but significant co-reaction of the contra-lateral, non-challenged eye was observed.
Collapse
Affiliation(s)
- D Sompolinsky
- Institute of Medical Microbiology, University of Copenhagen, Denmark
| | | | | |
Collapse
|
49
|
Winthereik MP, Lundberg L, Spärck JV, Katzenstein T, Sompolinsky D. Genetic control of eosinophilia in guinea pig strains inbred for high or low bronchial allergic reactivity. Allergy 1992; 47:103-9. [PMID: 1632477 DOI: 10.1111/j.1398-9995.1992.tb05096.x] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Abstract
Development of eosinophilia was studied in four strains of guinea pigs (gp), selectively bred for either high or low respiratory anaphylactic reactivity. One high-asthma strain (IMM/S 209) and one low-asthma strain (IMM/R 203) developed spontaneous high blood eosinophilia. The 2 other gp strains - one high-asthma strain (IMM/S 740) and one low-asthma strain (IMM/R 201-16) - maintained normal low levels of eosinophilic granulocytes (eos). The levels of eos in various tissues showed similar differences between the gp strains. Following immunization with ovalbumin/Al(OH)3 the levels of blood eos increased significantly only in gp of strain 209. The blood eos levels in gp of all 4 strains decreased significantly following immunization with ovalbumin in Freund's complete adjuvant (FCA).
Collapse
Affiliation(s)
- M P Winthereik
- Institute of Medical Microbiology, University of Copenhagen, Denmark
| | | | | | | | | |
Collapse
|
50
|
Abstract
A new objective method for measuring histaminedihydrochloride-induced bronchoconstriction in conscious guinea pigs has been developed. The aim of the present work was to investigate whether identical results could be obtained when the clinical observation of conscious guinea pigs with symptoms of respiratory distress (bronchoconstriction) was compared to an objective measuring technique of this parameter. An evaluation of the repeatability of the method was made and the respiration frequence (fR) and histaminedihydrochloride challenge concentration were compared to see whether there was a correlation between the two. Consequently, an apparatus was built that allowed simultaneous recording of breathing pattern and clinical observation of the animal being challenged. The breathing pattern was recorded by a strain-gauge transducer, connected to a measuring bridge, and the curves obtained on a jet ink x-y writer were used for calculating changes in duration of expiratory phase (Te) and fR. During the attacks of histaminedihydrochloride-induced bronchoconstriction a significantly prolonged Te could be calculated from the respiration curves. A high degree of agreement was found between this objective measure and clinically observed respiratory distress. The repeatability of the method was comparable to that of corresponding methods used for histaminedihydrochloride challenge in man. No obvious correlation was found between changes in fR and histaminedihydrochloride challenge concentration.
Collapse
Affiliation(s)
- A Engel
- Dept. of Pulmonary Medicine, Copenhagen County Hospital, Gentofte, Denmark
| | | | | | | |
Collapse
|